查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190339

人工耳蝸市場——增長、趨勢、COVID-19 的影響、預測 (2023-2028)

Cochlear Implants Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，人工耳蝸市場預計將以 8.57% 的複合年增長率增長。

最初，COVID-19 爆發的影響對尋求康復和麵臨植入技術挑戰的人工耳蝸植入患者的生活影響更深。 COVID-19 的爆發擾亂了對有聽力問題的人的診斷和治療。 結果，去醫院和診所的人次減少了。 Harper L. Wilson 等人在一項名為“COVID-19 大流行對聽力損失成人的溝通和醫療保健獲取的影響”的研究中。用戶和農村人口面臨更困難的情況，例如大流行病控制和醫療保健獲取，對所研究的市場產生不利影響。 評估了在大流行期間植入人工耳蝸的兒童所面臨的障礙。 此類研究表明，在 COVID-19 流行期間，對人工耳蝸的需求有所下降。 它影響了人工耳蝸手術和相關服務，但也激發了新的研究努力。 然而，由於免疫接種的進展和 COVID-19 病例數量的減少，預計該市場將在預測期內充分發揮其潛力。

此外，推動市場增長的主要因素包括不斷增長的老年人口中聽力受損的激增、年輕人因暴露於娛樂環境中的噪音而導致聽力受損的風險、人工耳蝸技術的進步和電池。這是延長壽命。

老齡化人口的聽力障礙是推動市場增長的一個因素。 老年人的聽力障礙負擔相對較高，預計將有助於未來幾年的市場增長。 例如，在 2021 年 6 月發表在 JAMA 網絡上的一項題為“美國社區老年人的年齡相關性聽力障礙與身體機能的關聯”的研究中，參與基於人群的隊列研究的美國老年人2956人中，973人（33%）聽力正常，1170人（40%）輕度聽力損失，692人（23%）中度聽力損失，121人（4%）重度聽力損失。 因此，隨著老年人口的增加，人工耳蝸的需求預計會增加。 此外，聽力損失和聽力困難是老年人的常見問題。 根據國家聾人和困難研究所 (NIDCD) 2022 年 3 月的一份報告，在美國 65 歲至 74 歲的人中，約有三分之一的人有聽力損失，75 歲及以上的人中約有一半有聽力損失。它一直與。 因此，預計老齡化社會聽力損失的高患病率將推動對人工耳蝸的需求，從而推動市場的擴大。

但是，主要市場參與者推出技術先進的產品將支持市場的增長。 例如，2021 年 8 月，Cochlear Limited 宣布推出 Nucleus Kanso 2 聲音處理器。 此次新發布反映了科利耳 (Cochlear) 對聽力技術創新的持續奉獻，以提供可放大的智能手機連接訪問，並幫助改善聽力損失者的聽力表現。 Nucleus Kanso 2 聲音處理器是世界上最小的耳後式人工耳蝸聲音處理器，採用聽力驗證技術。 此外，2021 年 2 月，Auditory Verbal United Kingdom 發起了人工耳蝸國際行動社區。 因此，所有上述因素都有望推動所研究市場的增長。 然而，這些植入物的高成本和維護難度限制了市場增長。

主要市場趨勢

預計在預測期內，單側植入部分將主導人工耳蝸市場

按類型來看，單側植入型預計將佔據主要市場份額。 與雙側植入相比，單側植入更受青睞，主要是因為其成本效益。 例如，根據一項題為“人工耳蝸的成本效益分析”的研究，題為“人工耳蝸的成本效益分析”的研究發表如下： 2021 年 3 月在 PubMed 上發表的一份社會觀點得出的結論是，對於患有進行性嚴重聽力損失的成年人和老年人，單側人工耳蝸的總經濟效益分別為 275,000 歐元和 76,000 歐元。 即使不考慮健康益處，社會影響也是有益的，尤其是對兒童和勞動者而言。 同樣，2021 年 11 月在 SpringerLink 上發表的一項題為“英國成年人單側人工耳蝸植入的成本效益”的研究發現，儘管臨床發生變化且醫療費用不斷上升，但單側人工耳蝸 (UCI) 表示它仍然具有成本效益。 在三年內，UCI 預計每年將成人和兒童植入物增加 70%，支出增加 2860 萬英鎊。 由於單邊嵌入，此類研究和成本效率預計將在分析期間推動該細分市場的增長。

此外，技術進步以及創新產品的推出可能會在未來幾年推動該細分市場的增長。 例如，2022 年 1 月，Cochlear Limited 獲得美國食品和藥物管理局 (US FDA) 批准用於治療單側聽力損失 (UHL) 或單側聽力損失 (SSD) 的人工耳蝸植入物。

因此，由於上述因素，預計該行業在預測期內將出現顯著增長。

預計北美將佔據人工耳蝸市場的最大份額

在北美，由於美國聽力損失人數的增加、植入技術的進步、人工耳蝸電池壽命的延長以及主要市場的存在等因素，美國占據了市場的領先份額業者經營，預計佔據。

根據加拿大統計局 2021 年 10 月的報告，總體而言，60% 的 19 至 79 歲加拿大人有聽力健康問題，包括聽力損失、耳鳴或兩者兼而有之。 聽力損失和耳鳴在男性中尤為常見。 根據同一份文件，聽力損失在加拿大老年人群中更為常見，因此，隨著人口老齡化的增加，聽力損失的負擔預計會增加，從而刺激該地區研究市場的擴張。 此外，在北美，由於該國聽力損失的高患病率和高發病率以及助聽器的高采用率，預計在預測期內美國將佔據助聽器市場的主要市場份額。 例如，根據美國國家聽力障礙研究所 2021 年 3 月的更新，在美國，每 1,000 名兒童中約有 2 至 3 名在出生時單耳或雙耳有可檢測到的聽力損失，並且年齡在 18 歲。約佔所有兒童的 15%美國成年人（3750 萬）報告存在某種形式的聽力損失。

此外，公司正在產品開發方面採取主動行動，以增加他們在所研究市場中的影響力。 例如，2021 年 6 月，奧迪康醫療宣布其 Neurosystem（人工耳蝸系統）專為患有雙側重度至重度感音神經性聽力損失的 18 歲兒童設計，他們在正確安裝助聽器後效果有限。獲得了上市前批准（ PMA）從美國食品和藥物管理局（FDA）為以下個人。 這些新興市場的發展預計將在不久的將來對市場增長產生積極影響。

競爭格局

人工耳蝸市場是一個綜合市場，由少數參與者組成。 接受調查的市場參與者包括 MED-EL Medical Electronics、Demant A/S、Nurotron Biotechnology 和 Sonova (Advanced Bionics Corp)。 其中許多公司位於美國和歐洲。 這些地區更加發達，因此擁有更好的醫療保健資金。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 人口老齡化的聽力障礙
    • 年輕人因接觸娛樂性噪音而導致聽力受損的風險
    • 人工耳蝸的技術進步和電池壽命的延長
  • 市場製約因素
    • 設備和維護成本高
    • 因手術受傷的風險
  • 搬運工五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（金額基礎：百萬美元）

  • 按類型
    • 單側植入
    • 雙側植入
  • 最終用戶
    • 兒科
    • 成人
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Cochlear Ltd（Oticon Medical）
    • MED-EL Medical Electronics
    • Nurotron Biotechnology Co Ltd
    • Sonova（Advanced Bionics Corp）
    • iotaMotion Inc.
    • Envoy Medical Corporation
    • Medtronic plc
    • Ototronix
    • Demant A/S

第7章 市場機會與今後動向

簡介目錄
Product Code: 66761

The Cochlear implants market is projected to register a CAGR of 8.57% during the forecast period, 2022-2027.

Initially, the impact of the COVID-19 outbreak was more profound on the lives of the cochlear implanted patients seeking habilitation and facing technical challenges with the implant. Due to COVID-19's breakout, there was a disruption in the diagnosis and treatment of people with hearing problems. As a result, fewer people visited hospitals and clinics. In the research study titled "Impacts of the COVID-19 Pandemic on Communication and Healthcare Access for Adults With Hearing Loss", by Harper L. Wilson et al in September 2021, during the COVID-19 pandemic, adult users of cochlear implants and people living in rural areas faced greater difficulties, including pandemic preparedness and access to healthcare, which has a detrimental effect on the market under study. evaluated the hurdles faced by cochlear implantee children during the pandemic. , such studies indicate that the demand for cochlear implants was reduced during the COVID-19 pandemic. Although the outbreak had an impact on cochlear implant surgery and related services, it also encouraged new research endeavors. However, the market under study is anticipated to reach its full potential over the forecast period due to ongoing vaccinations and a decline in COVID-19 cases.

Further, the major factors bolstering the market growth are the upsurge in hearing impairment in the growing geriatric population, the risk of hearing loss due to exposure to noise in recreational settings in the younger population, and technological advancements and increased battery life of cochlear implants.

Hearing impairment in the geriatric population is a major driver the market growth. The burden of hearing impairment in the older population is relatively high, and it is expected to aid the market growth over the coming years. For instance, a research study titled "Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US" published in JAMA Network, in June 2021, stated that 973 (33 %) of the 2,956 older people in United States who participated in the population-based cohort study had normal hearing, 1,170 (40%) had mild hearing impairment, 692 (23%) had moderate hearing impairment, and 121 (4%) had a severe hearing impairment. Thus, the demand for cochlear implants is expected to increase with the growing geriatric population. Moreover, hearing loss or difficulty in hearing is a common problem among older people. As per the National Institute on Deafness and Other Communication Disorders (NIDCD) report published in March 2022, approximately one in three people in United States between the ages of 65 and 74 has hearing loss and nearly half of those older than 75. As a result, the high prevalence of hearing loss among the aging population is anticipated to fuel demand for cochlear implants and thereby propel market expansion.

However, the launch of the technologically advanced product by the key market players support the market growth. For instance, In August 2021, Cochlear Limited introduced the Nucleus Kanso 2 Sound Processor. The new launch reflects Cochlear's ongoing dedication to innovation in hearing technology to provide amplifiable access to smartphone connectivity and aid in improving hearing performance in people with hearing loss. The Nucleus Kanso 2 Sound Processor is the smallest off-the-ear cochlear implant sound processor in the world with tested hearing performance technologies. Additionally, in February 2021, Auditory Verbal United Kingdom launched the Cochlear Implant International Community of Action. Thus all aforementioned factors are expected to drive the growth of the studied market. However, the high cost of these implants and the difficulty of maintenance have been restraining the market's growth.

Key Market Trends

Unilateral Implantation Segment is Expected to Dominate the Cochlear Implants Market Over the Forecast Period

By type, the unilateral implantations segment is expected to hold a major share of the market. Unilateral implantations are highly preferred compared to bilateral implantations, primarily due to their cost-effectiveness. For instance, according to a research study titled "Cost-benefit Analysis of Cochlear Implants: A Societal Perspective" published in PubMed, in March 2021, concluded that the adults and seniors with progressive severe hearing loss and unilateral cochlear implantation (CI) had a total net economic benefit of EUR 275,000 and EUR 76,000, respectively. Even without considering health advantages, the societal impact was beneficial for children and working people in particular. Similarly, a study titled "The cost-effectiveness of unilateral cochlear implants in United Kingdom adults" published in SpringerLink, in November 2021, stated that despite changes in clinical practice and rising healthcare unit costs, unilateral cochlear implants (UCIs) remain cost-effective. Within three years, UCIs are expected to boost annual implants in adults and children by 70% and spending by GBP 28.6 million. Such studies and cost efficiency offered by unilateral implantations are anticipated to boost the segment growth over the analysis period.

Moreover, technological advancements, along with innovative product launches, are likely to drive segment growth over the coming years. For instance, in January 2022, Cochlear Limited, obtained United States Food and Drug Administration (U.S. FDA) approval for Cochlear Nucleus Implants for the treatment of unilateral hearing loss (UHL) or single-sided deafness (SSD).

Thus, due to the factors mentioned above, the segment is expected to witness significant growth over the forecast period.

North America is Anticipated to Garner the Largest Share in Cochlear Implants Market

Within North America, United States is expected to hold a major share of the market owing to factors such as growth in hearing impairment among Americans, technological advancements concerning implants, increased battery life of cochlear implants, and the presence of major market players operating in the industry.

According to the October 2021 report of Statistics Canada, Overall, 60% of Canadians aged 19 to 79 had a hearing health issue, including audiometrically measured hearing loss, tinnitus, or both conditions. Hearing loss and tinnitus were particularly prevalent in men. According to the same source, hearing loss is more prevalent in older age groups in Canada; as a result, the burden of hearing loss is expected to increase as the older population grows, which is fueling the expansion of the region's studied market. Moreover, in North America, United States is expected to hold a major market share in the hearing aids market during the forecast period due to the high prevalence and incidence of hearing loss in the country and the high adoption of hearing aids. For instance, according to the March 2021 update from the National Institute on Deafness and Other Communication Disorders, about 2 to 3 out of every 1,000 children in United States were born with a detectable level of hearing loss in one or both ears, and approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing.

Furthermore, companies are taking initiatives to develop products to increase their presence in the market studied. For instance, in June 2021, Oticon Medical was granted United States Food and Drug Administration (U.S. FDA) premarket approval (PMA) for the company's Neuro System (cochlear implant system) to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from the appropriately fitted hearing aids. Such developments are likely to have a positive impact on the growth of the market in near future.

Competitive Landscape

The Cochlear Implants market is consolidated and consists of a few market players. Some of the key players in the market studied are MED-EL Medical Electronics, Demant A/S, Nurotron Biotechnology Co Ltd, and Sonova (Advanced Bionics Corp) among others. Majority of these companies are based in United States and Europe as these regions are more developed and hence better funded for healthcare.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Hearing Impairment in the Growing Geriatric Population
    • 4.2.2 Risk of Hearing Loss Due to Exposure to Noise in Recreational Settings in Younger Population
    • 4.2.3 Technological Advancements and Increased Battery Life of Cochlear Implants
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Device and Maintenance
    • 4.3.2 Risk of Injuries in Surgery
  • 4.4 Porters Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value-USD million)

  • 5.1 By Type
    • 5.1.1 Unilateral Implantation
    • 5.1.2 Bilateral Implantation
  • 5.2 By End User
    • 5.2.1 Pediatrics
    • 5.2.2 Adults
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cochlear Ltd (Oticon Medical)
    • 6.1.2 MED-EL Medical Electronics
    • 6.1.3 Nurotron Biotechnology Co Ltd
    • 6.1.4 Sonova (Advanced Bionics Corp)
    • 6.1.5 iotaMotion Inc.
    • 6.1.6 Envoy Medical Corporation
    • 6.1.7 Medtronic plc
    • 6.1.8 Ototronix
    • 6.1.9 Demant A/S

7 MARKET OPPORTUNITIES AND FUTURE TRENDS